BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37090519)

  • 21. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
    Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
    Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABAB receptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome.
    Wahlstrom-Helgren S; Klyachko VA
    J Physiol; 2015 Nov; 593(22):5009-24. PubMed ID: 26282581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased surface expression of the δ subunit of the GABA
    Zhang N; Peng Z; Tong X; Lindemeyer AK; Cetina Y; Huang CS; Olsen RW; Otis TS; Houser CR
    Exp Neurol; 2017 Nov; 297():168-178. PubMed ID: 28822839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensory Processing Phenotypes in Fragile X Syndrome.
    Rais M; Binder DK; Razak KA; Ethell IM
    ASN Neuro; 2018; 10():1759091418801092. PubMed ID: 30231625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of FMRP expression in adult V1 neurons rescues visual deficits in a mouse model of fragile X syndrome.
    Yang C; Tian Y; Su F; Wang Y; Liu M; Wang H; Cui Y; Yuan P; Li X; Li A; Gong H; Luo Q; Zhu D; Cao P; Liu Y; Wang X; Luo MH; Xu F; Xiong W; Wang L; Li XY; Zhang C
    Protein Cell; 2022 Mar; 13(3):203-219. PubMed ID: 34714519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive motor testing in Fmr1-KO mice exposes temporal defects in oromotor coordination.
    Roy S; Zhao Y; Allensworth M; Farook MF; LeDoux MS; Reiter LT; Heck DH
    Behav Neurosci; 2011 Dec; 125(6):962-9. PubMed ID: 22004265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered Developmental Expression of the Astrocyte-Secreted Factors Hevin and SPARC in the Fragile X Mouse Model.
    Wallingford J; Scott AL; Rodrigues K; Doering LC
    Front Mol Neurosci; 2017; 10():268. PubMed ID: 28900386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome.
    Lovelace JW; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2018 Jul; 115():39-48. PubMed ID: 29605426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
    Zhang L; Alger BE
    J Neurosci; 2010 Apr; 30(16):5724-9. PubMed ID: 20410124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
    Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA
    J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auditory processing in fragile x syndrome.
    Rotschafer SE; Razak KA
    Front Cell Neurosci; 2014; 8():19. PubMed ID: 24550778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome.
    Razak KA; Binder DK; Ethell IM
    Front Psychiatry; 2021; 12():720752. PubMed ID: 34690832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety.
    Schaefer TL; Davenport MH; Grainger LM; Robinson CK; Earnheart AT; Stegman MS; Lang AL; Ashworth AA; Molinaro G; Huber KM; Erickson CA
    J Neurodev Disord; 2017; 9():6. PubMed ID: 28616095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
    Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
    Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.
    Holley AJ; Shedd A; Boggs A; Lovelace J; Erickson C; Gross C; Jankovic M; Razak K; Huber K; Gibson JR
    Neurobiol Dis; 2022 Aug; 170():105767. PubMed ID: 35588990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus.
    Connor SA; Hoeffer CA; Klann E; Nguyen PV
    Learn Mem; 2011; 18(4):207-20. PubMed ID: 21430043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
    Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
    Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parallel learning and cognitive flexibility impairments between
    Schmitt LM; Arzuaga AL; Dapore A; Duncan J; Patel M; Larson JR; Erickson CA; Sweeney JA; Ragozzino ME
    Front Behav Neurosci; 2022; 16():1074682. PubMed ID: 36688132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the presence and absence of amino acids on translation, signaling, and long-term depression in hippocampal slices from Fmr1 knockout mice.
    Cooke SK; Russin J; Moulton K; Nadel J; Loutaev I; Gu Q; Li Z; Smith CB
    J Neurochem; 2019 Dec; 151(6):764-776. PubMed ID: 31539452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.